GHRP-2 (5mg)
This product is coming soon and is not yet available for purchase.
All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.
Order exactly what you need with no minimum quantity required, whether it’s a single unit or a larger order.
Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.
Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.
99% PURITY GUARANTEE
99% PURITY GUARANTEE
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC). Full analytical reports are available in the Certificate of Analysis section.
Preparation & Handling Notice
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
RESEARCH USE ONLY
This product is intended for research use only. It is not for human or veterinary use, not for diagnostic or therapeutic purposes, and should only be handled by qualified professionals.
Strength: 5 mg
CAS: 158861-67-7
Chemical Formula: C₄₅H₅₅N₉O₆
Molecular weight: 817.97 g/mol
Peptide Sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
Synonyms: GHRP2, Pralmorelin, Growth Hormon Releasing Peptide-2
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.
GHRP-2 is a synthetic hexapeptide classified under Muscle Growth & Performance Peptides. Supplied in a high-purity, lyophilized format, it is intended for laboratory research use. Also known as Pralmorelin, GHRP-2 is commonly studied for its interaction with growth hormone secretagogue receptors (GHSR-1a) in controlled in vitro and preclinical models.
-
Cold chain shipping available for temperature-sensitive products.
-
Orders are processed within 1–2 business days.
-
Delivery timelines vary by destination and shipping method — view our Shipping Policy for region-specific estimates.
-
Tracking information will be provided once shipped.
-
No order minimum applies.
-
If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.
We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.
All transactions are processed through a secure, PCI DSS–compliant system to ensure your data is fully protected.
Why Choose NOVERA COMPOUNDS Peptides?
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
- High-purity, research-grade peptide synthesis
- Analytical testing to verify quality and composition
- Consistent batch-to-batch performance
- Batch identification on every vial for traceability
- Stored and shipped under controlled conditions
High-purity, research-grade peptide synthesis
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
INFORMATION
What is GHRP-2 (5mg)?
GHRP-2 (5 mg), also known as Pralmorelin, is a synthetic hexapeptide classified as a muscle growth and performance peptide. It is primarily used in laboratory and preclinical research settings as a growth hormone secretagogue to study peptide-mediated endocrine signaling under controlled experimental conditions.
GHRP-2 is structurally designed to interact with the growth hormone secretagogue receptor (GHSR-1a), a receptor associated with ghrelin-related signaling pathways. Due to this interaction, researchers use GHRP-2 to investigate growth hormone release patterns, receptor activation dynamics, and downstream intracellular signaling cascades in both in vitro and animal model studies. The 5 mg presentation is ideal for small-scale, controlled experimental workflows requiring precise handling and reproducibility.
This product is strictly for laboratory research use and is not approved for human or veterinary applications.
Product Specifications
- CAS Number: 158861-67-7
- Peptide Sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂
- Molecular Formula: C₄₅H₅₅N₉O₆
- Molecular weight: 817.97 g/mol
- Synonyms: GHRP-2, Pralmorelin, Growth Hormone Releasing Peptide-2
- Purity: ≥95% (typically verified by HPLC and mass spectrometry)
- Packaging Format: 5 mg lyophilized powder in sealed research vial
- Storage Conditions: Store at −20 °C; protect from light and moisture
- Intended Use: For Laboratory Research Use Only
Key Characteristics of GHRP-2 (5mg)
- Synthetic hexapeptide designed for receptor-specific research
- Frequently used in endocrine and metabolic signaling studies
- Lyophilized format ensures stability and extended shelf life
- Analytical verification typically performed using HPLC and mass spectrometry
- Compatible with standard peptide handling and storage protocols
- Designed for controlled in vitro and preclinical research applications
How GHRP-2 (5mg) Supports Research
GHRP-2 (5 mg) is commonly used in laboratory studies to explore growth hormone–related signaling and ghrelin-associated receptor pathways. Researchers investigate how this peptide interacts with GHSR-1a receptors and influences intracellular signaling mechanisms, such as calcium mobilization and second-messenger pathways.
Due to its short-chain peptide structure and defined characteristics, GHRP-2 is often used in controlled experiments that investigate endocrine communication, receptor binding kinetics, and peptide stability in experimental systems. The 5 mg format is particularly suited for small-batch experimental designs and comparative peptide research.
Research Applications & Usage Information
GHRP-2 (5 mg) is commonly used in laboratory and preclinical research involving:
- Growth hormone secretagogue receptor (GHSR-1a) signaling studies
- Endocrine pathway modeling in vitro and in animal systems
- Peptide–receptor binding and activation assays
- Intracellular signaling and calcium-response investigations
- Comparative analysis of growth hormone–releasing peptides
- Metabolic regulation and energy-balance research frameworks
All applications are limited to controlled research environments and are investigational in nature.
Handling and Storage Recommendations
To preserve structural integrity and maintain research reliability:
- Store unopened vials at −20 °C in a dry, light-protected environment
- Avoid exposure to heat, humidity, and direct sunlight
- Allow the vial to equilibrate to room temperature before opening to prevent condensation
- After reconstitution, store solutions at 2–8 °C and use within laboratory-defined timeframes
- Avoid repeated freeze–thaw cycles to minimize degradation
Proper handling supports stability, reproducibility, and experimental reliability.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Laferrère B, Abraham C, Russell CD, Bowers CY. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab. 2005;90(2):611-614. doi:10.1210/jc.2004-1719
- Laferrère B, Hart AB, Bowers CY. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake. Obesity (Silver Spring). 2006;14(6):1056-1063. doi:10.1038/oby.2006.121
- National Center for Biotechnology Information. PubChem Compound Summary for CID 6918245, Pralmorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Pralmorelin.
- Yin Y, Li Y, Zhang W. The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int J Mol Sci. 2014;15(3):4837-4855. Published 2014 Mar 19. doi:10.3390/ijms15034837
What is GHRP-2 (5mg)?
GHRP-2 (5 mg), also known as Pralmorelin, is a synthetic hexapeptide classified as a muscle growth and performance peptide. It is primarily used in laboratory and preclinical research settings as a growth hormone secretagogue to study peptide-mediated endocrine signaling under controlled experimental conditions.
GHRP-2 is structurally designed to interact with the growth hormone secretagogue receptor (GHSR-1a), a receptor associated with ghrelin-related signaling pathways. Due to this interaction, researchers use GHRP-2 to investigate growth hormone release patterns, receptor activation dynamics, and downstream intracellular signaling cascades in both in vitro and animal model studies. The 5 mg presentation is ideal for small-scale, controlled experimental workflows requiring precise handling and reproducibility.
This product is strictly for laboratory research use and is not approved for human or veterinary applications.
Product Specifications
- CAS Number: 158861-67-7
- Peptide Sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂
- Molecular Formula: C₄₅H₅₅N₉O₆
- Molecular weight: 817.97 g/mol
- Synonyms: GHRP-2, Pralmorelin, Growth Hormone Releasing Peptide-2
- Purity: ≥95% (typically verified by HPLC and mass spectrometry)
- Packaging Format: 5 mg lyophilized powder in sealed research vial
- Storage Conditions: Store at −20 °C; protect from light and moisture
- Intended Use: For Laboratory Research Use Only
Key Characteristics of GHRP-2 (5mg)
- Synthetic hexapeptide designed for receptor-specific research
- Frequently used in endocrine and metabolic signaling studies
- Lyophilized format ensures stability and extended shelf life
- Analytical verification typically performed using HPLC and mass spectrometry
- Compatible with standard peptide handling and storage protocols
- Designed for controlled in vitro and preclinical research applications
How GHRP-2 (5mg) Supports Research
GHRP-2 (5 mg) is commonly used in laboratory studies to explore growth hormone–related signaling and ghrelin-associated receptor pathways. Researchers investigate how this peptide interacts with GHSR-1a receptors and influences intracellular signaling mechanisms, such as calcium mobilization and second-messenger pathways.
Due to its short-chain peptide structure and defined characteristics, GHRP-2 is often used in controlled experiments that investigate endocrine communication, receptor binding kinetics, and peptide stability in experimental systems. The 5 mg format is particularly suited for small-batch experimental designs and comparative peptide research.
Research Applications & Usage Information
GHRP-2 (5 mg) is commonly used in laboratory and preclinical research involving:
- Growth hormone secretagogue receptor (GHSR-1a) signaling studies
- Endocrine pathway modeling in vitro and in animal systems
- Peptide–receptor binding and activation assays
- Intracellular signaling and calcium-response investigations
- Comparative analysis of growth hormone–releasing peptides
- Metabolic regulation and energy-balance research frameworks
All applications are limited to controlled research environments and are investigational in nature.
Handling and Storage Recommendations
To preserve structural integrity and maintain research reliability:
- Store unopened vials at −20 °C in a dry, light-protected environment
- Avoid exposure to heat, humidity, and direct sunlight
- Allow the vial to equilibrate to room temperature before opening to prevent condensation
- After reconstitution, store solutions at 2–8 °C and use within laboratory-defined timeframes
- Avoid repeated freeze–thaw cycles to minimize degradation
Proper handling supports stability, reproducibility, and experimental reliability.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Laferrère B, Abraham C, Russell CD, Bowers CY. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab. 2005;90(2):611-614. doi:10.1210/jc.2004-1719
- Laferrère B, Hart AB, Bowers CY. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake. Obesity (Silver Spring). 2006;14(6):1056-1063. doi:10.1038/oby.2006.121
- National Center for Biotechnology Information. PubChem Compound Summary for CID 6918245, Pralmorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Pralmorelin.
- Yin Y, Li Y, Zhang W. The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int J Mol Sci. 2014;15(3):4837-4855. Published 2014 Mar 19. doi:10.3390/ijms15034837
Related products
